PH
Peter M Hecht

Peter M Hecht insider trades: Cyclerion Therapeutics (CYCN) stock buys and sales

Cyclerion Therapeutics Last trade Jun 3, 2021 46 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2012
2
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Peter reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 3, 2021CYCN↑ Buy$2.7M
May 6, 2021CYCN↑ Buy$734K
May 5, 2021CYCN↑ Buy$1.7M
Jan 25, 2019IRWD↓ Sell$1.1M
Dec 7, 2017IRWD↓ Sell$1.7M
Jan 12, 2017IRWD↓ Sell$1.0M
Mar 11, 2016IRWD↓ Sell$1.3M
Dec 15, 2015IRWD↓ Sell$813K
Mar 17, 2015IRWD↓ Sell$3.1M
Mar 3, 2015IRWD↓ Sell$999K
Nov 5, 2012IRWD↑ Buy$583K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Peter M Hecht's insider trades

Peter M Hecht is an insider at Cyclerion Therapeutics (CYCN). Since Nov 5, 2012, Peter has reported 4 open-market purchases worth $5.7M and 7 sales worth $10.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (18 filings), option exercises (12 filings), gifts (6 filings), other transactions (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYCN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.